Kannan Murugan
Jubilant Life Sciences (India)(IN)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Cancer therapeutics and mechanisms, Biochemical and Molecular Research, HIV/AIDS drug development and treatment, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis(2013)100 cited
- → Aminopyrazinamides: Novel and Specific GyrB Inhibitors that Kill Replicating and Nonreplicating Mycobacterium tuberculosis(2012)86 cited
- → Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate(2015)73 cited
- → Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure–activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-d-ribose 2′-oxidase(2015)58 cited
- → Structure Guided Lead Generation for M. tuberculosis Thymidylate Kinase (Mtb TMK): Discovery of 3-Cyanopyridone and 1,6-Naphthyridin-2-one as Potent Inhibitors(2014)44 cited
- → Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma(2020)34 cited
- → Synthesis and in vitro evaluation of novel 8-aminoquinoline–pyrazolopyrimidine hybrids as potent antimalarial agents(2015)30 cited
- → Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity(2016)24 cited
- → Synthesis of novel benzoxaborinin-4-ones and its application in indolin-2-ones synthesis using a Suzuki–Miyaura reaction protocol(2015)5 cited
- → Abstract 11: Novel dual inhibitors of LSD1-HDAC6/8 for treatment of cancer(2019)2 cited